The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Pharmacodynamic Profile of Short-term Abciximab Treatment Demonstrates Prolonged Platelet Inhibition With Gradual Recovery From GP IIb/IIIa Receptor Blockade
Abstract
Background —The glycoprotein (GP) IIb/IIIa receptor antagonist abciximab is approved for use in high-risk percutaneous coronary interventions. The purpose of the present study was to establish the pharmacodynamic profile and platelet-bound life span of abciximab. Methods and Results —The pharmacodynamics of abciximab (inhibition of ex vivo platelet aggregation and GP IIb/IIIa receptor blockade) were measured in 41 individuals who were randomized to receive a 0.25-mg/kg bolus and a 12-hour infusion of either 10 μg/min (EPIC regimen) or 0.125 μg · kg −1 · min −1 (EPILOG regimen) of the antiplatelet agent. At extended times, the amount and distribution of platelet-bound abciximab were monitored by flow cytometry. The EPIC and EPILOG infusion regimens exhibited equivalent blockade of both GP IIb/IIIa receptors and platelet aggregation throughout the duration of abciximab treatment. Flow cytometry revealed a single, highly fluorescent platelet population during treatment, consistent with complete saturation and homogeneous distribution of abciximab on circulating platelets. For 15 days after treatment, the fluorescence histograms remained unimodal with gradually diminishing fluorescence intensity, indicating decreasing levels of platelet-bound abciximab. At 8 and 15 days, which exceeds the normal circulating life span of platelets, median relative fluorescence intensity corresponded to 29 100 (29% GP IIb/IIIa receptor blockade) and 13 300 (13% GP IIb/IIIa receptor blockade) abciximab molecules bound per platelet, respectively. Conclusions —These results are consistent with continuous reequilibration of abciximab among circulating platelets and may explain the gradual recovery of platelet function and long-term prevention of ischemic complications by abciximab after coronary intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
BORN, G. V. R. (1962) · Nature · doi:10.1038/194927b0 · Cited by 4,294
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
(1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362401 · Cited by 1,883
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.
Steele, P. M., Chesebro, J. H., Stanson, A. W., Holmes, D. R., Dewanjee, M. K., Badimon, L., & Fuster, V (1985) · Circulation Research · doi:10.1161/01.res.57.1.105 · Cited by 632
Structure and Function of Leukocyte Integrins
Larson, R. S., & Springer, T. A. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00565.x · Cited by 599
Effect of Heparin and Heparin Fractions on Platelet Aggregation
Salzman, E. W., Rosenberg, R. D., Smith, M. H., Lindon, J. N., & Favreau, L. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109661 · Cited by 591
Coller, B. S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111931 · Cited by 576
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets
Wagner, C., Mascelli, M., Neblock, D., Weisman, H., Coller, B., & Jordan, R. (1996) · Blood · doi:10.1182/blood.v88.3.907.907 · Cited by 460
Self-citationTcheng, J. E., Ellis, S. G., George, B. S., Kereiakes, D. J., Kleiman, N. S., Talley, J. D., Wang, A. L., Weisman, H. F., Califf, R. M., & Topol, E. J. (1994) · Circulation · doi:10.1161/01.cir.90.4.1757 · Cited by 410
Self-citationReverter, J. C., Béguin, S., Kessels, H., Kumar, R., Hemker, H. C., & Coller, B. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118859 · Cited by 393
Cited by
Patrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Weitz, J. I., Eikelboom, J. W., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2294 · Cited by 527
Steinhubl, S. R., Talley, J. D., Braden, G. A., Tcheng, J. E., Casterella, P. J., Moliterno, D. J., Navetta, F. I., Berger, P. B., Popma, J. J., Dangas, G., et al. (2001) · Circulation · doi:10.1161/01.cir.103.21.2572 · Cited by 355
Thiele, H., Schindler, K., Friedenberger, J., Eitel, I., Fürnau, G., Grebe, E., Erbs, S., Linke, A., Möbius-Winkler, S., Kivelitz, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.747642 · Cited by 303
Evaluation of Platelet Function by Flow Cytometry
Michelson, A. D., Barnard, M. R., Krueger, L. A., Frelinger, A. L., & Furman, M. I. (2000) · Methods · doi:10.1006/meth.2000.1006 · Cited by 271
Metadata
- Authors
- Mascelli, M. A., Lance, E. T., Damaraju, L., Wagner, C. L., Weisman, H. F., & Jordan, R. E.
- Venue
- Circulation
- Published
- 1998-05-05
- Volume
- 97
- Issue
- 17
- Pages
- 1680-1688
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2023252309
- Cited by
- 282
- References
- 17
- FWCI
- 27.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacodynamic Profile of Short-term Abciximab Treatment Demonstrates Prolonged Platelet Inhibition With Gradual Recovery From GP IIb/IIIa Receptor Blockade. https://app.cochat.ai/papers/10.1161/01.cir.97.17.1680
- The paper
- Mascelli, M. A., Lance, E. T., Damaraju, L., Wagner, C. L., Weisman, H. F., & Jordan, R. E. (1998). Pharmacodynamic Profile of Short-term Abciximab Treatment Demonstrates Prolonged Platelet Inhibition With Gradual Recovery From GP IIb/IIIa Receptor Blockade. Circulation. https://doi.org/10.1161/01.cir.97.17.1680
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.